1. A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide‐containing regimens. (18th November 2016) Authors: Sanchez, Larysa; Vesole, David H.; Richter, Joshua R.; Biran, Noa; Bilotti, Elizabeth; McBride, Laura; Anand, Palka; Ivanovski, Kristin; Siegel, David S. Journal: British journal of haematology Issue: Volume 176:Number 3(2017) Page Start: 440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies. (January 2021) Authors: Sanchez, Larysa; Dardac, Alexandra; Madduri, Deepu; Richard, Shambavi; Richter, Joshua Journal: Therapeutic advances in hematology Issue: Volume 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bronchial-oesophageal fistula: a rare initial presentation of squamous cell carcinoma of the lung. (10th June 2015) Authors: Duma, Narjust; Barlow, Christian; Sanchez, Larysa; Sadikot, Sean Journal: BMJ case reports Issue: Volume 2015 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma. Issue 1 (December 2016) Authors: Sanchez, Larysa; Wang, Yucai; Siegel, David; Wang, Michael Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Elotuzumab for the treatment of multiple myeloma. Issue 1 (December 2016) Authors: Wang, Yucai; Sanchez, Larysa; Siegel, David; Wang, Michael Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review. Issue 9 (1st September 2020) Authors: Sanchez, Larysa; Barley, Kevin; Richter, Joshua; Franz, Joseph; Cho, Hearn Jay; Jagannath, Sundar; Madduri, Deepu; Parekh, Samir; Richard, Shambavi; Chari, Ajai Journal: Expert review of hematology Issue: Volume 13:Issue 9(2020) Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. No needles needed: All-oral therapy options for relapsed and refractory multiple myeloma. (January 2023) Authors: Franz, Joseph; Myrus, Elizabeth; Sanchez, Larysa; Richter, Joshua Journal: Blood reviews Issue: Volume 57(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin. Issue 1 (23rd October 2018) Authors: Chihara, Dai; Wong, Shannon; Feldman, Tatyana; Fanale, Michelle A.; Sanchez, Larysa; Connors, Joseph M.; Savage, Kerry J.; Oki, Yasuhiro Journal: Hematological oncology Issue: Volume 37:Issue 1(2019) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone. Issue 10 (12th July 2021) Authors: Sanchez, Larysa; Leleu, Xavier; Beaumont, Jennifer L.; Yu, Hailin; Hudgens, Stacie; Simonova, Maryana; Auner, Holger W.; Quach, Hang; Delimpasi, Sosana; Špička, Ivan; Pour, Ludĕk; Kriachok, Iryna; Dimopoulos, Meletios A.; Usenko, Ganna; Hájek, Roman; Benjamin, Reuben; Sinha, Dinesh Kumar; Venner,... Journal: American journal of hematology Issue: Volume 96:Issue 10(2021) Page Start: E383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m2. Issue 2 (22nd December 2019) Authors: Barley, Kevin; Sanchez, Larysa; Cho, Hearn J.; Parekh, Samir; Madduri, Deepu; Richter, Joshua; Isola, Luis; Goldstein, Talia; Dhadwal, Amishi; Zarychta, Katarzyna; Sanchez, Gillian Morgan; Catamero, Donna; Verina, Daniel; Florendo, Erika; Yum, Moon‐hee; La, Lisa; Gullie, Jude; Chan, Elaine; Jagan... Journal: American journal of hematology Issue: Volume 95:Issue 2(2020:Feb.) Page Start: E51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗